Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum]

Total article views   HTML views PDF downloads Totals
7,165 Dovepress* 7,056+ 1,427 8,483
PubMed Central* 109 53 162
Totals 7,165 1,480 8,645
*Since 19 April 2017

View citations on PubMed and Google Scholar